肿瘤微环境异质性的研究进展

doi:10.11904/j.issn.1002-3070.2017.03.014

Abstract

Abstract: The tumor microenvironment plays a vital role in the process of tumorigenesis and development.Studies have been confirmed that the tumor microenvironment heterogeneity has a huge impact on the tumor efficacy and drug resistance.This review summarizes the relationship between immune cells and related immune factors in tumor microenvironment as well as vascular endothelial cell heterogeneity and tumor progression and prognosis.So it is better help us understand the tumor microenvironment heterogeneity for the impact of the tumor.This will conduce to us through a variety of methods to enhance the body′s anti-tumor ability by inhibiting and killing tumor cells.

Key words: Tumor microenvironment, Heterogeneity, Immune

CLC Number:

XU Yang,QIN Qi,ZHAO Hong,LIU Jianhong,ZHANG Qingyuan. Research progress of tumor microenvironment heterogeneity[J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(3): 258-261.

References

1 Kothari AN,Mi Z,Zapf M,et al.Novel clinical therapeutics targeting the epithelial to mesenchymal transition[J].Clin Transl Med,2014,3(1):35-49.
2 Thomas PD,Kahn M.Kat3 coactivators in somatic stem cells and cancer stem cells:biological roles,evolution,and pharmacologic manipulation[J].Cell Biol Toxicol,2016,32(1):61-81.
3 Zhang D,Chen Z,Wang DC,et al.Regulatory T cells and potential inmmunotherapeutic targets in lung cancer[J].Cancer Metastasis Rev,2015,34(2):277-290.
4 Shi L,Wang L,Hou J,et al.Targeting roles of inflammatory microenvironment in lung cancer and metastasis[J].Cancer Metastasis Rev,2015,34(2):319-331.
5 Yang D,Zhou J,Zeng T,et al.Serum chemokine network correlates with chemotherapy in non-small cell lung cancer[J].Cancer Lett,2015,365(1):57-67.
6 Nemenoff R.Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis[J].PLos One,2011,6(12):403-404.
7 Phillips JD,Knab LM,Blatner NR,et al.Preferential expansion of pro-inflammatory Tregs in human non-small cell lung cancer[J].Cancer Immunol Immunother,2015,64(9);1185-1191.
8 Huang P,Xu X,Wang L,et al.The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment[J].J Cell Mol Med,2014,18(2):218-230.
9 Janols H,Bergenfelz C,Allaoui R,et al.A high frequency of MDSCs in sepsis patients,with the granulocytic subtype dominating in gram-positive cases[J].J Leukoc Biol,2014,96(5):685-693.
10 Zhang B,Wang Z,Wu L,et al.Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma[J].PLoS One,2013,8(2):e57114.
11 Ortiz ML,Lu L,Ramachandran I,et al.Myeloid-derived suppressor cells in the development of lung cancer[J].Cancer Immunol Res,2014,2(1):50-58.
12 Hasegawa T,Suzuki H,Yamaura T,et al.Prognostic value of peripheral and local forkhead box P3(+)regulatory T cells in patients with non-small-cell lung cancer[J].Mol Clin Oncol,2014,2(5):685-694.
13 Goc J,Germain C,Vobourgais TKD,et al.Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+T cells[J].Cancer Res,2014,74(3):705-715.
14 Fridman WH,Galon J,Dieu-Nosjean MC,et al.Immune infiltration in human cancer:prognostic significance and disease control[J].Curr Top Microbiol Immunol,2011,344(1):1-24.
15 Huang S,Fang R,XU J,et al.Evaluation of the tumor targeting a FAP-α based doxorubicin prodrug[J].Drug Target,2011,19(7):487-496.
16 Kalluri R,Weinberg RA.The basics of epithelial-mesenchymal transition[J].J Clin Invest,2009,119(6):1420-1428.
17 Lippitz BE.Cytokine patterns in patients with cancer:a systematic review[J].Lancet Oncol,2013,14(6):218-228.
18 Houghton AM,Rzymkiewicz DM,Ji H,et al.Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth[J].Nat Med,2010,16(2):219-223.
19 Katerina A,Denis ITI,Raphaela S,et al.Impaired T-bet-pSTAT1α and perforin-mediated immune responses in the tumoral region of lung adenocarcinoma[J].Br J Cancer,2015,113(6):902-913.
20 Choi H,Sheng J,Gao D,et al.Transcriptome analysis of individual stromal cell populations identifies stroma-tumor crosstalk in mouse lung cancer model[J].Cell Rep,2015,10(7):1187-1201.
21 Shimizu.K,Okita.R,Nakata.M.Clinical significance of the tumor microenvironment in non-small cell lung cancer[J].Ann Transl Med,2013,1(2):20-23.
22 Nagaraj S,Gabrilovich DI.Myeloid-derived suppressor cells in human cancer[J].Cancer J,2010,16(4):348-353.
23 Yang L,Huang J,Ren X,et al.Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis [J].Cancer Cell,2008,13(1):23-35.
24 Wang L,Yi T,Kortylewski M,et al.IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway[J].J Exp Med,2009,206(7):1457-1464.
25 Grivennikov SI,Greten FR,Karin M.Immunity,inflammation,and cancer[J].Cell,2010,140(6):883-899.
26 Krausgruber T,Blazek K,Smallie T,et al.IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses [J].Nat Immunol,2011,12(3):231-238.
27 Gardner JC,Noel JG,Nikolaidis NM,et al.G-CSF drives a posttraumatic immune program that protects the host from infection[J].J Immunol,2014,192(5):2405-2417.
28 Ding G,Niu J,Li Y.Dental pulp stem cells suppress the proliferation of lymphocytes via transforming growth factor-β1[J].Hum Cell,2015,28(2):81-90.
29 Rafii S,Avecilla ST,Jin DK.Tumor vasculature address book:identification of stage-specific tumor vessel zip codes by phage display[J].Cancer Cell,2003,4(5):331-333.
30 Junttila MR,De Sauvage FJ.Influence of tumour micro-environment heterogeneity on therapeutic response[J].Nature,2013,501(7467):346-354.

[1]	LIU Hengchen, ZHANG Xinyu. Toll-like receptor signaling pathway as a potential therapeutic target for colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 188-192.
[2]	FU Yanli, YU Yang, WEI Wei, ZOU Jingjing, SUN Xiang. Study on predicting the cervical cancinogenesis by high-risk human papillomavirus load and the unbalanced expression of Th1/Th2 [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 533-537.
[3]	LI Yue, XU Ke, HAN Zengxiang, SUN Min, FAN Guohua, ZHANG Yong. Advances in the role of tumor-associated macrophage in colon cancer and targeted therapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 450-454.
[4]	LV Qiang, CHEN Hongsheng, LI Guodong, WEI Jiufeng, LIU Ming. Effects of tumor-associated fibroblasts in the development of colorectal cancer and its research progress [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 275-279.
[5]	MA Chao, WANG Guonian. Effects of anesthetics on immune function in perioperative cancer patients [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 285-288.
[6]	ZHANG Pei, CAO Shoubo, YU Yan. Research progress of autophagy-mediated regulation of tumor associated macrophages [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 130-134.
[7]	LEI Wanting, WANG Jingxuan. Effects of tumor microenvironment on aerobic glycolysis of tumor cells [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 189-192.
[8]	WANG Qinghui, SUN Yue, JIANG Wanwei. Clinical effect of flurbiprofen axetil in the postoperative analgesia of cervical cancer surgery [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 33-37.
[9]	MIAO Suping, GUO Erliang, PEI Rong, JIANG Huanyu, MIAO Susheng. Research progress in miRNA regulatory immune checkpoint in cancer therapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 57-62.
[10]	SHEN Meiying, PANG Da. Regulation of long non-coding RNAs in the tumor microenvironment [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 73-76.
[11]	ZENG Yulan,LIU Yangyang,LIANG Jinyan,GU Feifei,LIU Li. Advances in drug resistance mechanism of immunological checkpoint inhibitors and post-drug resistant therapeutic strategy [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(4): 353-358.
[12]	QIN Qi,XU Yang,ZHAO Hong,ZHANG Qingyuan. Research progress of tumor-associated neutrophils [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(4): 367-370.
[13]	LI Henan,ZHANG Ruiqin. Factors of immunolosical function in patients with cancer surgery [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(2): 183-187.
[14]	CHAI Jingbo, LI Ping, PEI Zhiping. The effects and mechanism of Lycopene on immune function of ovarian cancer rats [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(1): 13-17.
[15]	NI Shouhua, YUE Xiaolong, WU Jin. The transcription factor X-box binding protein-1 in tumorigenesis and development of cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(1): 65-68.

Research progress of tumor microenvironment heterogeneity

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments